Dermatology and Venereology

The Department of Dermatology was established in 1999, concurrent with the founding of the hospital, and has now developed into a modern discipline integrating medical care, teaching, scientific research, and training. It is a Key Clinical Specialty of Guangdong Province, a Key Medical Discipline of Shenzhen, a Leading Discipline of Shenzhen, and a Brand Discipline of Shenzhen. In 2018, it ranked first among single disciplines in Dermatology in the “12th Five-Year Plan” Shenzhen Hospital Science and Technology Influence Rankings. For many consecutive years, it has been included in the Dermatology Reputation Rankings for the South China region in the Fudan China Hospital and Specialty Reputation Rankings.

The Department of Dermatology currently has 48 employees in total (29 physicians), including 18 with senior professional titles, 15 with doctoral degrees, 9 with master’s degrees, 1 doctoral supervisor, and 5 master’s supervisors. The discipline has 1 Shenzhen municipal-level leading talent, 1 Outstanding Young Medical Talent of Guangdong Province, 3 reserve talents of Shenzhen, and 2 overseas high-level talents of Shenzhen. In recent years, multiple academic backbones have been selected and sent to renowned domestic and international institutions for advanced training in dermatology research.

The Dermatology outpatient department covers an area of 1,300 square meters and includes a dermatological disease diagnosis and treatment area, a dermatological laser cosmetology area, and a dermatologic surgery diagnosis and treatment area. It has 10 hospital beds and a laboratory covering 200 square meters. It is equipped with more than 30 advanced domestic and international diagnostic and treatment devices, including pigment lasers, vascular lasers, intense pulsed light, monopolar radiofrequency, fractional radiofrequency, semiconductor lasers, a fungal fluorescence detection system, a dermatoscope, a skin photoreaction simulator, a multi-person viewing system, and a fluorescence microscope. The Institute of Dermatology is equipped with dozens of high-end scientific research instruments, including a low-temperature freezer, a real-time quantitative PCR instrument, a cryostat, an ultracentrifuge, a multicolor flow cytometer, a laser microdissection system, and an automated slide-scanning system.

The Department has six subspecialties: immune-mediated skin diseases, dermatopathology and difficult-to-diagnose and severe skin diseases, infectious skin diseases, dermatologic surgery and skin tumors, dermatological cosmetology, and genodermatoses. It operates eight specialty clinics for dermatologic surgery; atopic dermatitis and eczema; urticaria; chronic prurigo; cutaneous hemangiomas and vascular malformations (port-wine stains); acne and rosacea; psoriasis; and hereditary skin diseases.

Immune-mediated skin diseases: For patients with severe atopic dermatitis/eczema, urticaria, bullous diseases, psoriasis, vitiligo, and other conditions, the department provides specialized diagnostic and treatment services including allergen screening, patch testing, biologic therapy, narrowband ultraviolet phototherapy, and excimer light therapy.

Dermatologic surgery: The annual number of procedures exceeds 6,000, covering benign and malignant skin tumors such as keloids, basal cell carcinoma of the skin, and squamous cell carcinoma.

Laser cosmetology: The annual number of diagnostic and treatment visits exceeds 20,000. Skin lasers, radiofrequency, dermal fillers, botulinum toxin, skin nutrients, and other treatments are used to treat pigmentation, acne and rosacea, as well as for skin rejuvenation and contouring.

Photodynamic therapy: The annual number of treatments exceeds 1,000. It is used to treat benign and malignant skin tumors, condyloma acuminatum, and port-wine stains, offering advantages including a low recurrence rate and good cosmetic results.

In the future, the Department will use the Department of Dermatology of Peking University Shenzhen Hospital as its clinical base, and the “Shenzhen Key Laboratory of Translational Medicine for Skin Diseases,” the “Shenzhen Public Service Platform for Molecular Testing of Skin Diseases,” and the “Institute of Dermatology, Peking University Shenzhen Hospital” as its scientific research platforms. Focusing on the six core subspecialties, it will develop a series of cutting-edge technologies, cultivate high-level academic talent, and build a brand discipline leading Shenzhen and serving as a regional center for Central and Southern China.